429 related articles for article (PubMed ID: 26519740)
1. MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA.
Liu X; Madhankumar AB; Miller PA; Duck KA; Hafenstein S; Rizk E; Slagle-Webb B; Sheehan JM; Connor JR; Yang QX
Neuro Oncol; 2016 May; 18(5):691-9. PubMed ID: 26519740
[TBL] [Abstract][Full Text] [Related]
2. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
Li Y; Liu G; Lou X; Chen Z; Ma L
Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
[TBL] [Abstract][Full Text] [Related]
3. Combined molecular MRI and immuno-spin-trapping for in vivo detection of free radicals in orthotopic mouse GL261 gliomas.
Towner RA; Smith N; Saunders D; De Souza PC; Henry L; Lupu F; Silasi-Mansat R; Ehrenshaft M; Mason RP; Gomez-Mejiba SE; Ramirez DC
Biochim Biophys Acta; 2013 Dec; 1832(12):2153-61. PubMed ID: 23959048
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment.
Claes A; Gambarota G; Hamans B; van Tellingen O; Wesseling P; Maass C; Heerschap A; Leenders W
Int J Cancer; 2008 May; 122(9):1981-6. PubMed ID: 18081012
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylserine-targeted liposome for enhanced glioma-selective imaging.
Zhang L; Habib AA; Zhao D
Oncotarget; 2016 Jun; 7(25):38693-38706. PubMed ID: 27231848
[TBL] [Abstract][Full Text] [Related]
6. Cellular uptake and in vitro antitumor efficacy of composite liposomes for neutron capture therapy.
Peters T; Grunewald C; Blaickner M; Ziegner M; Schütz C; Iffland D; Hampel G; Nawroth T; Langguth P
Radiat Oncol; 2015 Feb; 10():52. PubMed ID: 25889824
[TBL] [Abstract][Full Text] [Related]
7. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
8. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
10. Paramagnetic perfluorocarbon-filled albumin-(Gd-DTPA) microbubbles for the induction of focused-ultrasound-induced blood-brain barrier opening and concurrent MR and ultrasound imaging.
Liao AH; Liu HL; Su CH; Hua MY; Yang HW; Weng YT; Hsu PH; Huang SM; Wu SY; Wang HE; Yen TC; Li PC
Phys Med Biol; 2012 May; 57(9):2787-802. PubMed ID: 22510713
[TBL] [Abstract][Full Text] [Related]
11. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic changes induced by focused ultrasound in glioma-bearing rats using dynamic contrast-enhanced MRI measurement.
Zhao YL; Xia X; Liang CE; Li XM
J Biol Regul Homeost Agents; 2018; 32(3):655-661. PubMed ID: 29921395
[TBL] [Abstract][Full Text] [Related]
13. MR imaging of tumor angiogenesis using sterically stabilized Gd-DTPA liposomes targeted to CD105.
Zhang D; Feng XY; Henning TD; Wen L; Lu WY; Pan H; Wu X; Zou LG
Eur J Radiol; 2009 Apr; 70(1):180-9. PubMed ID: 18541399
[TBL] [Abstract][Full Text] [Related]
14. A choline derivate-modified nanoprobe for glioma diagnosis using MRI.
Li J; Huang S; Shao K; Liu Y; An S; Kuang Y; Guo Y; Ma H; Wang X; Jiang C
Sci Rep; 2013; 3():1623. PubMed ID: 23563908
[TBL] [Abstract][Full Text] [Related]
15. Comparison of USPIO-enhanced MRI and Gd-DTPA enhancement during the subacute stage of focal cerebral ischemia in rats.
Yang YM; Feng X; Yin le K; Li CC; Jia J; Du ZG
Acta Radiol; 2014 Sep; 55(7):864-73. PubMed ID: 24065200
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of 201Tl-SPECT and MRI using Gd-DTPA for glioma].
Yamada T; Maruoka S; Yamada S; Sonobe M
Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Jul; 59(8):402-8. PubMed ID: 10459285
[TBL] [Abstract][Full Text] [Related]
17. Correlation of emmprin expression in vascular endothelial cells with blood-brain-barrier function: a study using magnetic resonance imaging enhanced by Gd-DTPA and immunohistochemistry in brain tumors.
Sameshima T; Nabeshima K; Toole BP; Inoue T; Yokogami K; Nakano S; Ohi T; Wakisaka S
Virchows Arch; 2003 Jun; 442(6):577-84. PubMed ID: 12719975
[TBL] [Abstract][Full Text] [Related]
18. In vitro study of novel gadolinium-loaded liposomes guided by GBI-10 aptamer for promising tumor targeting and tumor diagnosis by magnetic resonance imaging.
Gu MJ; Li KF; Zhang LX; Wang H; Liu LS; Zheng ZZ; Han NY; Yang ZJ; Fan TY
Int J Nanomedicine; 2015; 10():5187-204. PubMed ID: 26316749
[TBL] [Abstract][Full Text] [Related]
19. The synthesis of a D-glucosamine contrast agent, Gd-DTPA-DG, and its application in cancer molecular imaging with MRI.
Zhang W; Chen Y; Guo DJ; Huang ZW; Cai L; He L
Eur J Radiol; 2011 Sep; 79(3):369-74. PubMed ID: 21106316
[TBL] [Abstract][Full Text] [Related]
20. Investigation using an HER-2/neu transgenic mouse model of a newly developed MR contrast agent with the effect of an antitumor drug.
Sonoda A; Nitta N; Ohta S; Nitta-Seko A; Murata S; Jo J; Tabata Y; Takahashi M; Tani T; Murata K
J Magn Reson Imaging; 2009 Oct; 30(4):907-10. PubMed ID: 19787744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
